Related Experiment Video
Updated: May 3, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Improving antibiotic prescribing for children in the resource-poor setting
Kirsty Le Doare1, Charlotte I S Barker, Adam Irwin
1Paediatric Infectious Diseases Research Group, St George's University of London, Cranmer Terrace, London, SW17 0RE, UK; Wellcome Trust Centre for Global Health Research, Imperial College, Norfolk Place, London, W2 1NY, UK.
Insights
Antibiotic use in low- and middle-income countries (LMICs) is vital for child health but often inappropriate. Improving prescribing practices requires better access to medicines and evidence-based guidelines to combat antimicrobial resistance.
Area of Science:
- Global Health
- Pediatric Pharmacology
- Antimicrobial Stewardship
Background:
- Antibiotics are essential for treating infectious diseases, the primary cause of mortality in children in low- and middle-income countries (LMICs).
- Inappropriate antibiotic use, including incorrect prescribing and patient adherence, is widespread globally, contributing to antimicrobial resistance.
- LMICs face significant challenges in implementing policies for rational antibiotic use in pediatric care.
Purpose of the Study:
- To provide an overview of the challenges and strategies for rational antibiotic prescribing in pediatric populations within LMICs.
- To highlight the impact of inappropriate antibiotic use on antimicrobial resistance and child mortality.
- To discuss future developments that could enhance antibiotic prescribing in LMICs.
Main Methods:
- Review of existing literature and World Health Organization (WHO) initiatives related to pediatric medicine use in LMICs.
- Analysis of barriers to rational antibiotic prescribing in resource-limited settings.
- Discussion of strategies for improving access to appropriate medications and clinical guidelines.
Main Results:
- Inappropriate antibiotic use is a major concern in LMICs, exacerbating antimicrobial resistance.
- WHO initiatives like 'Make medicines child size' are crucial steps but require continued support.
- Persistent barriers hinder the effective implementation of rational prescribing policies.
Conclusions:
- Improving access to appropriate pediatric formulations and strengthening evidence-based guidelines are essential for rational antibiotic use in LMICs.
- Addressing inappropriate antibiotic use is critical to combatting antimicrobial resistance and reducing child mortality.
- Future developments must focus on sustainable strategies to enhance pediatric antibiotic prescribing in resource-limited settings.
Abstract:
Antibiotics are a critically important part of paediatric medical care in low- and middle-income countries (LMICs), where infectious diseases are the leading cause of child mortality. The World Health Organization estimates that >50% of all medicines are prescribed, dispensed or sold inappropriately and that half of all patients do not take their medicines correctly. Given the rising prevalence of antimicrobial resistance globally, inappropriate antibiotic use is of international concern, and countries struggle to implement basic policies promoting rational antibiotic use. Many barriers to rational paediatric prescribing in LMICs persist. The World Health Organization initiatives, such as 'Make medicines child size', the Model List of Essential Medicines for Children and the Model Formulary for Children, have been significant steps forward. Continued strategies to improve access to appropriate drugs and formulations, in conjunction with improved evidence-based clinical guidelines and dosing recommendations, are essential to the success of such initiatives on both a national and an international level. This paper provides an overview of these issues and considers future developments that may improve LMIC antibiotic prescribing.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Mechanism of Antibiotic Resistance in MRSA
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antibiotic Selection

